Drug-induced Nephrotoxicity Treatment Market, Global Outlook and Forecast 2022-2028

May 2022 | 62 pages | ID: D425E3556BC2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drug-induced Nephrotoxicity Treatment in Global, including the following market information:

Global Drug-induced Nephrotoxicity Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Drug-induced Nephrotoxicity Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Steroid Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drug-induced Nephrotoxicity Treatment include Roche Diagnostic Limited, Siemens Healthcare, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Aushon BioSystem, Epistem and G.E. Healthcare and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug-induced Nephrotoxicity Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drug-induced Nephrotoxicity Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Drug-induced Nephrotoxicity Treatment Market Segment Percentages, by Type, 2021 (%)

• Steroid Therapy
• Others

Global Drug-induced Nephrotoxicity Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Drug-induced Nephrotoxicity Treatment Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical and Biotechnology Companies
• Academic Institutes
• Research Organizations
• Others

Global Drug-induced Nephrotoxicity Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Drug-induced Nephrotoxicity Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drug-induced Nephrotoxicity Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Drug-induced Nephrotoxicity Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Diagnostic Limited
• Siemens Healthcare
• Abbott Laboratories
• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• Aushon BioSystem
• Epistem
• G.E. Healthcare
• Affymetrix

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drug-induced Nephrotoxicity Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drug-induced Nephrotoxicity Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUG-INDUCED NEPHROTOXICITY TREATMENT OVERALL MARKET SIZE

2.1 Global Drug-induced Nephrotoxicity Treatment Market Size: 2021 VS 2028
2.2 Global Drug-induced Nephrotoxicity Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drug-induced Nephrotoxicity Treatment Players in Global Market
3.2 Top Global Drug-induced Nephrotoxicity Treatment Companies Ranked by Revenue
3.3 Global Drug-induced Nephrotoxicity Treatment Revenue by Companies
3.4 Top 3 and Top 5 Drug-induced Nephrotoxicity Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drug-induced Nephrotoxicity Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug-induced Nephrotoxicity Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Drug-induced Nephrotoxicity Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drug-induced Nephrotoxicity Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Drug-induced Nephrotoxicity Treatment Market Size Markets, 2021 & 2028
  4.1.2 Steroid Therapy
  4.1.3 Others
4.2 By Type - Global Drug-induced Nephrotoxicity Treatment Revenue & Forecasts
  4.2.1 By Type - Global Drug-induced Nephrotoxicity Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Drug-induced Nephrotoxicity Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drug-induced Nephrotoxicity Treatment Market Size, 2021 & 2028
  5.1.2 Pharmaceutical and Biotechnology Companies
  5.1.3 Academic Institutes
  5.1.4 Research Organizations
  5.1.5 Others
5.2 By Application - Global Drug-induced Nephrotoxicity Treatment Revenue & Forecasts
  5.2.1 By Application - Global Drug-induced Nephrotoxicity Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Drug-induced Nephrotoxicity Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Drug-induced Nephrotoxicity Treatment Market Size, 2021 & 2028
6.2 By Region - Global Drug-induced Nephrotoxicity Treatment Revenue & Forecasts
  6.2.1 By Region - Global Drug-induced Nephrotoxicity Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Drug-induced Nephrotoxicity Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Drug-induced Nephrotoxicity Treatment Revenue, 2017-2028
  6.3.2 US Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.3.3 Canada Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.3.4 Mexico Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Drug-induced Nephrotoxicity Treatment Revenue, 2017-2028
  6.4.2 Germany Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.4.3 France Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.4.4 U.K. Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.4.5 Italy Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.4.6 Russia Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.4.8 Benelux Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Drug-induced Nephrotoxicity Treatment Revenue, 2017-2028
  6.5.2 China Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.5.3 Japan Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.5.4 South Korea Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.5.6 India Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Drug-induced Nephrotoxicity Treatment Revenue, 2017-2028
  6.6.2 Brazil Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.6.3 Argentina Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drug-induced Nephrotoxicity Treatment Revenue, 2017-2028
  6.7.2 Turkey Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.7.3 Israel Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028
  6.7.5 UAE Drug-induced Nephrotoxicity Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche Diagnostic Limited
  7.1.1 Roche Diagnostic Limited Corporate Summary
  7.1.2 Roche Diagnostic Limited Business Overview
  7.1.3 Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.1.4 Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.1.5 Roche Diagnostic Limited Key News
7.2 Siemens Healthcare
  7.2.1 Siemens Healthcare Corporate Summary
  7.2.2 Siemens Healthcare Business Overview
  7.2.3 Siemens Healthcare Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.2.4 Siemens Healthcare Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.2.5 Siemens Healthcare Key News
7.3 Abbott Laboratories
  7.3.1 Abbott Laboratories Corporate Summary
  7.3.2 Abbott Laboratories Business Overview
  7.3.3 Abbott Laboratories Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.3.4 Abbott Laboratories Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.3.5 Abbott Laboratories Key News
7.4 Thermo Fisher Scientific
  7.4.1 Thermo Fisher Scientific Corporate Summary
  7.4.2 Thermo Fisher Scientific Business Overview
  7.4.3 Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.4.4 Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.4.5 Thermo Fisher Scientific Key News
7.5 Agilent Technologies
  7.5.1 Agilent Technologies Corporate Summary
  7.5.2 Agilent Technologies Business Overview
  7.5.3 Agilent Technologies Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.5.4 Agilent Technologies Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.5.5 Agilent Technologies Key News
7.6 Bio-Rad Laboratories
  7.6.1 Bio-Rad Laboratories Corporate Summary
  7.6.2 Bio-Rad Laboratories Business Overview
  7.6.3 Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.6.4 Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bio-Rad Laboratories Key News
7.7 Aushon BioSystem
  7.7.1 Aushon BioSystem Corporate Summary
  7.7.2 Aushon BioSystem Business Overview
  7.7.3 Aushon BioSystem Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.7.4 Aushon BioSystem Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.7.5 Aushon BioSystem Key News
7.8 Epistem
  7.8.1 Epistem Corporate Summary
  7.8.2 Epistem Business Overview
  7.8.3 Epistem Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.8.4 Epistem Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.8.5 Epistem Key News
7.9 G.E. Healthcare
  7.9.1 G.E. Healthcare Corporate Summary
  7.9.2 G.E. Healthcare Business Overview
  7.9.3 G.E. Healthcare Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.9.4 G.E. Healthcare Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.9.5 G.E. Healthcare Key News
7.10 Affymetrix
  7.10.1 Affymetrix Corporate Summary
  7.10.2 Affymetrix Business Overview
  7.10.3 Affymetrix Drug-induced Nephrotoxicity Treatment Major Product Offerings
  7.10.4 Affymetrix Drug-induced Nephrotoxicity Treatment Revenue in Global Market (2017-2022)
  7.10.5 Affymetrix Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Drug-induced Nephrotoxicity Treatment Market Opportunities & Trends in Global Market
Table 2. Drug-induced Nephrotoxicity Treatment Market Drivers in Global Market
Table 3. Drug-induced Nephrotoxicity Treatment Market Restraints in Global Market
Table 4. Key Players of Drug-induced Nephrotoxicity Treatment in Global Market
Table 5. Top Drug-induced Nephrotoxicity Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drug-induced Nephrotoxicity Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drug-induced Nephrotoxicity Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drug-induced Nephrotoxicity Treatment Product Type
Table 9. List of Global Tier 1 Drug-induced Nephrotoxicity Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug-induced Nephrotoxicity Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drug-induced Nephrotoxicity Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drug-induced Nephrotoxicity Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drug-induced Nephrotoxicity Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drug-induced Nephrotoxicity Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Roche Diagnostic Limited Corporate Summary
Table 31. Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Product Offerings
Table 32. Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Siemens Healthcare Corporate Summary
Table 34. Siemens Healthcare Drug-induced Nephrotoxicity Treatment Product Offerings
Table 35. Siemens Healthcare Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Laboratories Corporate Summary
Table 37. Abbott Laboratories Drug-induced Nephrotoxicity Treatment Product Offerings
Table 38. Abbott Laboratories Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Product Offerings
Table 41. Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Agilent Technologies Corporate Summary
Table 43. Agilent Technologies Drug-induced Nephrotoxicity Treatment Product Offerings
Table 44. Agilent Technologies Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bio-Rad Laboratories Corporate Summary
Table 46. Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Product Offerings
Table 47. Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Aushon BioSystem Corporate Summary
Table 49. Aushon BioSystem Drug-induced Nephrotoxicity Treatment Product Offerings
Table 50. Aushon BioSystem Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Epistem Corporate Summary
Table 52. Epistem Drug-induced Nephrotoxicity Treatment Product Offerings
Table 53. Epistem Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 54. G.E. Healthcare Corporate Summary
Table 55. G.E. Healthcare Drug-induced Nephrotoxicity Treatment Product Offerings
Table 56. G.E. Healthcare Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Affymetrix Corporate Summary
Table 58. Affymetrix Drug-induced Nephrotoxicity Treatment Product Offerings
Table 59. Affymetrix Drug-induced Nephrotoxicity Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Drug-induced Nephrotoxicity Treatment Segment by Type in 2021
Figure 2. Drug-induced Nephrotoxicity Treatment Segment by Application in 2021
Figure 3. Global Drug-induced Nephrotoxicity Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drug-induced Nephrotoxicity Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drug-induced Nephrotoxicity Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug-induced Nephrotoxicity Treatment Revenue in 2021
Figure 8. By Type - Global Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 12. US Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 24. China Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drug-induced Nephrotoxicity Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drug-induced Nephrotoxicity Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Siemens Healthcare Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Laboratories Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Agilent Technologies Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aushon BioSystem Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Epistem Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. G.E. Healthcare Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Affymetrix Drug-induced Nephrotoxicity Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)